A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96 percent sensitivity.
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96 percent sensitivity.